Literature DB >> 29699812

A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects.

C Morgantini1, S Trifirò2, D Tricò3, D Meriwether4, S Baldi2, A Mengozzi2, S T Reddy4, A Natali5.   

Abstract

BACKGROUND AND AIMS: High-cholesterol and high-fat diets alter biochemical composition and anti-oxidant properties of high-density lipoproteins (HDL) in animals. Whether this occurs in humans is unknown. Therefore, we examined the effect of a short-term elevation in dietary cholesterol and fat intake on HDL composition in healthy subjects. METHODS AND
RESULTS: In a randomized, crossover clinical trial, 14 healthy young volunteers followed a 14-day low-cholesterol/low-fat diet (LChF) and a 14-day isocaloric high-cholesterol/high-fat diet (HChF) in a random order. After each diet, we measured HDL concentrations of hydroxyeicosatetraenoic acids (HETE), hydroxyoctadecadienoic acids (HODE), and haptoglobin, as well as serum amyloid A (SAA) and paroxonase-1 activity (PON-1). HDL concentrations of 15-HETE (+254%, p = 0.002), 5-HETE (+116%, p = 0.004), 13-HODE (+102%, p = 0.049), and SAA levels (+75%, p = 0.007) were significantly higher after the HChF than after the LChF. Furthermore, haptoglobin was marginally increased (+32%, p = 0.091) while PON-1 activity was unaffected (-16%, p = 0.366) by the HChF.
CONCLUSION: In healthy subjects, a short-term elevation in dietary cholesterol and fat intake increases HDL lipid hydroperoxide content (15-HETE, 5-HETE, 13-HODE) and SAA levels, which are key features of dysfunctional HDL. This is the first study showing that a physiologic manipulation of dietary cholesterol and fat intake affects HDL lipidome and proteome in healthy subjects independently of weight changes. CLINICAL TRIAL REGISTRATION: NCT02549144.
Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Cholesterol; High density lipoprotein; High-fat diet; Oxidized lipids; Serum amyloid A

Mesh:

Substances:

Year:  2018        PMID: 29699812     DOI: 10.1016/j.numecd.2018.03.005

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

Review 1.  Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?

Authors:  Elisa Mattavelli; Alberico Luigi Catapano; Andrea Baragetti
Journal:  Nutrients       Date:  2021-10-25       Impact factor: 5.717

2.  Reply to Landry et al. Findings from Diet Comparison Difficult to Interpret in the Absence of Adherence Assessment. Comment on "Tricò et al. Effects of Low-Carbohydrate versus Mediterranean Diets on Weight Loss, Glucose Metabolism, Insulin Kinetics and β-Cell Function in Morbidly Obese Individuals. Nutrients 2021, 13, 1345".

Authors:  Domenico Tricò; Diego Moriconi; Monica Nannipieri
Journal:  Nutrients       Date:  2021-10-21       Impact factor: 5.717

Review 3.  The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials.

Authors:  Erik Froyen; Bonny Burns-Whitmore
Journal:  Nutrients       Date:  2020-08-04       Impact factor: 5.717

4.  High-Density Lipoproteins and Mediterranean Diet: A Systematic Review.

Authors:  Elena Grao-Cruces; Lourdes M Varela; Maria E Martin; Beatriz Bermudez; Sergio Montserrat-de la Paz
Journal:  Nutrients       Date:  2021-03-16       Impact factor: 5.717

Review 5.  Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials.

Authors:  Albert Sanllorente; Camille Lassale; Maria Trinidad Soria-Florido; Olga Castañer; Montserrat Fitó; Álvaro Hernáez
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.